Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Resproly Logo
Resproly Growth Score
37
CB Rank
113607
Heat Score
35
Resproly is a respiratory system inhalation therapy and device developer.
Founded
obfuscation
PrivateSeries B Zhuhai, Guangdong, China101-250 www.resproly.com/
Biopharma
Biotechnology
Health Care
Medical
Overview

Resproly
Total Funding
obfuscation
Growth Score
37
Heat Score
35

Total Funding
obfuscation
Series B raised
obfuscation
Growth Score37
1 pts
in past quarter
Heat Score 35
-15 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Resproly

CB Rank
113607
Resproly is a respiratory system inhalation therapy and device developer.
Founded
obfuscation
PrivateSeries B Zhuhai, Guangdong, China101-250 www.resproly.com/
Biopharma
Biotechnology
Health Care
Medical

Funding Rounds

Series B
OBF
in
obfuscation
Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Key People

Details

Legal Name Shenzhen Resipril Biopharmaceutical Co., Ltd.
Also Known As 瑞思普利
Operating Status Active
Company Type For Profit
Founders  Yongqi Chen
About the Company
Resproly is a research and development, production and sales of formula and equipment for respiratory inhalation. An integrated enterprise that focuses on multiple clinically demanding treatment areas such as Asthma, Chronic Obstructive Pulmonary Disease (COPD), Diabetes, and Parkinson's Disease.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Dry Powder Inhaler (DPI) Development
Development of dry powder inhalers that deliver micronized drugs or carriers in single or multiple doses for patient inhalation.
Nebulized Inhaler Development
Development of nebulized inhalers that convert drug solutions, emulsions, or suspensions into mist for patient inhalation using specialized devices.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Resproly Logo
Series B - Resproly
3
obfuscation
Qianhai Fund of FundsSeries B
obfuscation
Series B - Resproly Logo
Series B - Resproly
3
obfuscation
Qianhai Fund of FundsSeries B
obfuscation
Series B - Resproly Logo
Series B - Resproly
3
obfuscation
Qianhai Fund of FundsSeries B
obfuscation
Series B - Resproly Logo
Series B - Resproly
3
obfuscation
Qianhai Fund of FundsSeries B
obfuscation
Series B - Resproly Logo
Series B - Resproly
3
obfuscation
Qianhai Fund of FundsSeries B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Resproly Logo
Series B - Resproly
3
obfuscation
Qianhai Fund of FundsSeries B
obfuscation
Series B - Resproly Logo
Series B - Resproly
3
obfuscation
Qianhai Fund of FundsSeries B
obfuscation
Series B - Resproly Logo
Series B - Resproly
3
obfuscation
Qianhai Fund of FundsSeries B
obfuscation
Series B - Resproly Logo
Series B - Resproly
3
obfuscation
Qianhai Fund of FundsSeries B
obfuscation
Series B - Resproly Logo
Series B - Resproly
3
obfuscation
Qianhai Fund of FundsSeries B

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

453
53.56%
 in past month

Active Website Tech Count

5Resproly is actively using 5 technologies for its website, according to BuiltWith. These include Viewport Meta, CommonCrawl Top 50m, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Resproly's headquarters? Resproly is located in Zhuhai, Guangdong, China.Who invested in Resproly? Resproly has 7 investors including Qianhai Fund of Funds and  Fuho Capital.When was the last funding round for Resproly? Resproly closed its last funding round on
obfuscation
from a Series B round.Who are Resproly's competitors? Alternatives and possible competitors to Resproly may include The Stevanato Group, Cipla, and  Recipharm.How much funding has Resproly raised to date? Resproly has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3e39328 1)
|